Savoy Pharmaceuticals
Savoy Pharmaceuticals Inc.: Specializing in oncology, virology, and immunology treatments across the US.
Founded
2004Savoy Pharmaceuticals Inc.: Specializing in oncology, virology, and immunology treatments across the US.
Founded with a mission to revolutionize healthcare, Savoy Pharmaceuticals Inc. focuses on developing innovative treatments for oncology, virology, and immunology. The company's core vision is to provide groundbreaking therapies that address unmet medical needs in cancer and viral diseases. Their flagship products, Oncoprev™ and Viroprev™, are designed to combat various types of cancer and terminal viral infections, respectively. Savoy Pharmaceuticals markets its advanced therapeutic solutions primarily within the United States.
Savoy Pharmaceuticals has garnered attention through its collaborations with leading scientific advisors and industry experts. The company has achieved significant milestones in the development of its proprietary technologies and has secured several patents to protect its intellectual property. By advancing the treatment landscape for critical illnesses, Savoy Pharmaceuticals has made a substantial impact on the pharmaceutical industry, offering hope to patients with previously limited options.
Companies similar to Savoy Pharmaceuticals include Sova Pharmaceuticals, Vyriad, Karyopharm Therapeutics and Tavotek Biotherapeutics.
Savoy Pharmaceuticals was founded in 2004.
Savoy Pharmaceuticals' headquarters is located in Salt Lake City, UT, US.
Savoy Pharmaceuticals' most recent funding round was for $2.5M (USD) in January 2014.
As of Jan 28, 2014, Savoy Pharmaceuticals has disclosed funding of $2.5M (USD). Undisclosed round amounts are excluded.
Savoy Pharmaceuticals has 11 employees as of Feb 4, 2024.
Tavotek Biotherapeutics
tavotek.com
